The company reported $1.4 million in worldwide orthopedics sales, which was slightly below the $1.5 million reported in the first quarter of 2011. The company’s international orthopedics sales increased 2.6 percent, which offset a decrease in the U.S. market.
During the first quarter, the company reported $271 million in expenses related to litigation and the DePuy ASC Hip recall costs.
More Articles on Orthopedic Devices:
Johnson & Johnson’s Synthes Acquisition Finally Approved
NLT Spine Receives CE Mark for Discectomy Device
Stryker Q1 Sales Soar 7.2%, Spine Sales Driven by Acquisitions
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
